Sesen Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Sesen Bio and buy or sell other stocks, ETFs, and their options commission-free!About SESN
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOSteven Kelly, MBA
CEOSteven Kelly, MBA
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
SESN Key Statistics
Market cap26.28M
Market cap26.28M
Price-Earnings ratio0.24
Price-Earnings ratio0.24
Dividend yield—
Dividend yield—
Average volume269.87K
Average volume269.87K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.27
52 Week high$1.27
52 Week low$0.0261
52 Week low$0.0261
Stock Snapshot
The current Sesen Bio(SESN) stock price is $0.63, with a market capitalization of 26.28M. The stock trades at a price-to-earnings (P/E) ratio of 0.24.
Sesen Bio(SESN) stock opened on 2025-12-26 at —. The price climbed to — and dipped to —.
Sesen Bio(SESN) shares are trading with a volume of 0, against a daily average of 269.87K.
During the past year, Sesen Bio(SESN) stock moved between $0.03 at its lowest and $1.27 at its peak.
During the past year, Sesen Bio(SESN) stock moved between $0.03 at its lowest and $1.27 at its peak.
People also own
Based on the portfolios of people who own SESN. This list is generated using Robinhood data, and it’s not a recommendation.